J. Neumiller

Diabetes Care · 2013–2022

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from J. Neumiller's perspective

Ordered by how strongly the researchers J. Neumiller trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. (New England Journal of Medicine)
  2. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  3. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. (The Lancet Diabetes and Endocrinology)
  4. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. (American Journal of Kidney Diseases)
  5. Kidney disease and increased mortality risk in type 2 diabetes. (Journal of the American Society of Nephrology)
  6. Diabetes and Hypertension: A Position Statement by the American Diabetes Association (Diabetes Care)
  7. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition. (Diabetes Research and Clinical Practice)
  8. American Diabetes Association Standards of Medical Care in Diabetes 2017 (Journal of Diabetes)
  9. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. (American Journal of Kidney Diseases)
  10. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. (Journal of the American Medical Association (JAMA))

Their papers